CD8A and neoplasm: Furthermore, via the action of anaphylatoxins, the complement system may also lead to an increased anti-tumor effect of immune cells, such as CD8+ T lymphocytes, suggesting that the complement system is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response [29].